The grey market premium (GMP) for Gem Aromatics IPO stands at +26, suggesting that its shares were trading at a premium of ...

Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...